Quantitative Analysis of the Structural Requirements for Blockade of the N-Methyl-d-aspartate Receptor at the Phencyclidine Binding Site
- 1 January 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (3) , 393-400
- https://doi.org/10.1021/jm9704412
Abstract
Blockade of the N-methyl-d-aspartate receptor by uncompetitive antagonists has implications for symptomatic and neuroprotective therapy of various neuropsychiatric diseases. Since the three-dimensional (3D) structure of this ion channel is unknown, the structural requirements for uncompetitive inhibition were investigated by application of a three-step strategy: At first, Ki values were measured for a number of structurally diverse compounds at the phencyclidine (PCP) binding site in postmortem human frontal cortex. Second, a pharmacophore model was developed for this set of molecules employing a mathematical method called graph theory. The resulting pharmacophore provided a very good explanation for the ability of structurally diverse compounds to bind to the same binding site. Using the experimental data and the pharmacophore as a basis for the third step, a three-dimensional quantitative structure−activity relationship (3D-QSAR) applying comparative molecular field analysis (CoMFA) was performed. The QSAR proved to be highly consistent and showed good predictiveness for several additional molecules. The results give a deeper insight into the structural requirements for effective NMDA receptor antagonism and offer the opportunity for improved drug design. The study represents the first quantitative 3D-QSAR model for NMDA receptor blockade, and it comprises structurally very different molecules. That the alignment for a highly consistent CoMFA is based on an automated 3D pharmacophore analysis has important methodological implications.Keywords
This publication has 26 references indexed in Scilit:
- Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapyBiological Psychiatry, 1997
- The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channelsTrends in Neurosciences, 1993
- Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complexJournal of Medicinal Chemistry, 1993
- Source specificity of early calcium neurotoxicity in cultured embryonic spinal neuronsJournal of Neuroscience, 1993
- Structural requirements for the development of potent acid (NMDA) receptor antagonistsBiochemical Pharmacology, 1993
- Role of hydrogen bonding in ligand interaction with the N-methyl-D-aspartate receptor ion channelJournal of Medicinal Chemistry, 1990
- Excitotoxic Amino Acids and Neuropsychiatric DisordersAnnual Review of Pharmacology and Toxicology, 1990
- Distinctive structural requirement for the binding of uncompetitive blockers (phencyclidine-like drugs) to the NMDA receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteinsJournal of the American Chemical Society, 1988
- Comparison of Phencyclidine Hydrochloride (Sernyl) with Other DrugsArchives of General Psychiatry, 1962